Table 1.
Isolated from | Isolated Flavonoids | Total Flavonoid Content | Type of Cancer | Mechanism of Action | Anticancer Assay | Ref. |
---|---|---|---|---|---|---|
Milk thistle (Silybum marianum) | Silybin or silibinin | N/A | cervical (HeLa) and hepatoma (Hep3B) human cancer cells | Inhibits hypoxia-inducible factor-1a and mTOR/p70S6K/4E-BP1 signaling pathway | N/A | [65] |
Silybin | Modified Flavonoids silybin derivatives namely 2,3-dehydrosilybin (DHS), 7-O-methylsilybin (7OM), 7-Ogalloylsilybin (7OG), 7,23-disulphatesilybin (DSS), 7-O-palmitoylsilybin (7OP), and 23-O-palmitoylsilybin (23OP) |
N/A | human bladder cancer HTB9, colon cancer HCT116 and prostate carcinoma PC3 cells | silybin strongly synergizes human prostate carcinoma cells to doxorubicin-, cisplatin-, carboplatin-, and mitoxantrone-induced growth inhibition and apoptotic death | N/A | [66] |
Silybum marianum | Silybin nanosuspension | N/A | human prostatic carcinoma PC-3 cell line | silybin nanosuspension induced PC-3 cell growth inhibition and Silybin nanosuspension-induced apoptosis may occur in the G1 phase. | N/A | [67] |
Silybum marianum | Silibinin | N/A | MCF-7 breast cancer cells. | blocks rapamycin signaling with a concomitant reduction in translation initiation | N/A | [68] |
Cnidoscolus quercifolius | N/A | N/A | prostate (PC3 and PC3-M) and breast (MCF-7) cancer cells | N/A | N/A | [69] |
Lasiosiphon eriocephalus | N/A | N/A | HeLa and MCF-7 | N/A | N/A | [70] |
Onions, Kale, French beans, lettuce etc | Quercetin | N/A | ovarian PA-1 cancer cell line | quercetin induces the mitochondrial-mediated apoptotic pathway, and thus, it inhibits the growth of 17 metastatic ovarian cancer cells | N/A | [71] |
Stachys tmolea | Erbascoside, chlorogenic acid, andapigenin7-glucoside | Total flavonoids (mg QEs/g dry plant) 4.98 ± 0.06 |
N/A | N/A | N/A | [72] |
Cassia occidentalis, Callistemon viminalis, Cleome viscosa and Mimosa hamata | N/A | C. viminalis (46.41 ± 2.23 mg of CAE/g DW) and M. hamata (40.33 ± 1.16 mg of CAE/g DW) followed by C. viscosa leaves (36.22 ± 0.74 mg of CAE/g DW), C. occidentalis (35.32 ± 0.70 mg of CAE/g DW) and C. viscosa root (33.63 ± 1.25 mg of CAE/g DW) | human breast cancer cell line MCF-7 | anti-angiogenic activity via inhibition of blood constituents density in vessels | SRB assay | [73] |
Brassica oleracea var. alboglabra | N/A | N/A | human cancer cell lines (colon cancer cell line SW480, liver cancer cell line HepG2, cervical cancer line HeLa, and lung cancer line A549 | N/A | MTT assay | [74] |
Melodorum siamensis | N/A | N/A | pancreatic β cell line MIN-6 cells | Nuclear factor-κB inhibition | N/A | [75] |